BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16092153)

  • 1. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes.
    Cutlip DE; Kuntz RE
    Circulation; 2005 Aug; 112(6):916-22; discussion 922. PubMed ID: 16092153
    [No Abstract]   [Full Text] [Related]  

  • 2. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes.
    Bhatt DL; Topol EJ
    Circulation; 2005 Aug; 112(6):906-15; discussion 923. PubMed ID: 16087811
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Porto I; Van Gaal W; Banning A
    Eur Heart J; 2005 Oct; 26(20):2206; author reply 2206-7. PubMed ID: 16087650
    [No Abstract]   [Full Text] [Related]  

  • 4. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR).
    Wang TY; Peterson ED; Dai D; Anderson HV; Rao SV; Brindis RG; Roe MT;
    J Am Coll Cardiol; 2008 May; 51(21):2068-74. PubMed ID: 18498965
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of creatine kinase release after percutaneous coronary intervention.
    Cavallini C; Rugolotto M; Savonitto S
    Ital Heart J; 2005 Jun; 6(6):522-9. PubMed ID: 16008158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial damage in successful single vessel coronary angioplasty as assessed by creatinine kinase and its myocardium band isoenzyme levels.
    Abbas S; Tayyab F; Samor NA; Shabir M; Kayani AM
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):142-6. PubMed ID: 18460240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).
    Linefsky JP; Lin M; Pieper KS; Reist CJ; Berdan LG; Antman EM; Goodman SG; French JK; Guneri S; Roe MT; Newby LK; Harrington RA; Ferguson JJ; Califf RM; Mahaffey KW
    Am J Cardiol; 2009 Nov; 104(10):1330-5. PubMed ID: 19892046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of periprocedural creatine kinase-MB isoenzyme release on long-term mortality in contemporary percutaneous coronary intervention.
    Andron M; Stables RH; Egred M; Alahmar AE; Shaw MA; Roberts E; Albouaini K; Grayson AD; Perry RA; Palmer ND
    J Invasive Cardiol; 2008 Mar; 20(3):108-12. PubMed ID: 18316825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality.
    Prasad A; Singh M; Lerman A; Lennon RJ; Holmes DR; Rihal CS
    J Am Coll Cardiol; 2006 Nov; 48(9):1765-70. PubMed ID: 17084247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.
    Lindsay J; Canos DA; Apple S; Pinnow E; Aggrey GK; Pichard AD
    Am J Cardiol; 2004 Sep; 94(6):786-9. PubMed ID: 15374790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental progress? The roles of direct stenting and routine troponin measurement after percutaneous coronary intervention.
    Ellis SG
    J Invasive Cardiol; 2002 Apr; 14(4):171-2. PubMed ID: 11923568
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic and prognostic significance of CK-MB, troponins, CRP, BNP and/or NT-proBNP in coronary angioplasty. Elevation mechanisms and clinical implications].
    Bertinchant JP; Ledermann B; Schmutz L; Pezzano M; Jamaleddin N; Cade S; Winum PF; Polge A
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):925-33. PubMed ID: 18209693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures.
    Salem M; Rotevatn S; Stavnes S; Brekke M; Pettersen R; Kuiper K; Ulvik R; Nordrehaug JE
    Int J Cardiol; 2005 Sep; 104(2):144-51. PubMed ID: 16168806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.